We are live on ! Find out more
ACB

Aristotle Capital Boston Portfolio holdings

AUM $1.61B
1-Year Est. Return 19.82%
This Fund
S&P 500
This Quarter Est. Return
+11.47%
1 Year Est. Return
+19.82%
3 Year Est. Return
+51.6%
5 Year Est. Return
+74.11%
10 Year Est. Return
+400.29%
AUM
$730M
AUM Growth
+$169M
Cap. Flow
+$111M
Cap. Flow %
15.2%
Top 10 Hldgs %
18.73%
Holding
130
New
27
Increased
88
Reduced
13
Closed
2

Sector Composition

Rank Sector Weight
1 Industrials 19.94%
2 Technology 17.32%
3 Financials 16.14%
4 Healthcare 11.97%
5 Consumer Discretionary 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RRC icon
126
Range Resources
RRC
$9.33B
$475K 0.07%
+13,829
New +$495K
TROX icon
127
Tronox
TROX
$967M
$283K 0.04%
+27,448
New +$274K
QEP
128
DELISTED
QEP RESOURCES, INC.
QEP
$232K 0.03%
+12,591
New +$229K
FFWM
129
DELISTED
First Foundation Inc
FFWM
-255,948
Closed -$3.16M
AMSG
130
DELISTED
Amsurg Corp
AMSG
-152,518
Closed -$10.2M

Similar funds

Aristotle Capital Boston's Q4 2016 Portfolio in Review

As of Q4 2016, Aristotle Capital Boston held 130 positions worth $730M, up 30% from $561M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Aristotle Capital Boston deployed $111M of net new capital in Q4 2016, opening 27 new positions and adding to 88 existing holdings. Its largest new stake was Envision Healthcare Holdings Inc: 184,286 shares worth $11.7M.

By sector, the portfolio is most concentrated in Industrials at 20% of assets, down from 21% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Wabash National, an estimated $1.35M trimmed.

  • Aristotle Capital Boston's largest Q4 2016 buy was Envision Healthcare Holdings Inc: 184,286 shares worth $11.7M.
  • Aristotle Capital Boston added most to iShares Russell 2000 ETF in Q4 2016, an estimated $9.41M increase.
  • Aristotle Capital Boston's biggest Q4 2016 reduction was Wabash National, cutting an estimated $1.35M.
  • Aristotle Capital Boston fully exited Amsurg Corp in Q4 2016, selling an estimated $10.2M.
  • Aristotle Capital Boston's ten largest holdings make up 19% of its $730M portfolio in Q4 2016.
  • Aristotle Capital Boston opened 27 new positions and closed 2 in Q4 2016.
  • Aristotle Capital Boston's portfolio value rose 30% quarter-over-quarter to $730M.

Based on Aristotle Capital Boston's 13F filing for Q4 2016, filed 14 Feb 2017.